Global health: A uniquely Egyptian epidemic

Nature

Volumn 474, Issue 7350 SUPPL., 2011, Pages

  Yahia, Mohammed ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANTIBODY; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE SPREAD; DISEASE TRANSMISSION; DISEASE TREATMENT; EPIDEMIC; GENOTYPE; HEALTH EXPENDITURE; HEALTH POLICY; HEALTH SERVICES; HEPATITIS; VIRUS;

ARTICLE; DRUG COST; EGYPT; FUNDING; GENOTYPE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PREVALENCE; PRIORITY JOURNAL; SOCIOECONOMICS; VIRUS GENE;

EGYPT; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFECTION CONTROL; MEDICAL WASTE; PREVALENCE; SCHISTOSOMIASIS;

EGYPT;

EID: 79958808909     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/474S12a     Document Type: Article

References (4)

1. El-Zanaty F. & Way, A. Egypt Demographic and Health Survey 2008 (Egyptian Ministry of Health, El-Zanaty and Associates and Macro International, 2009).
2. Miller, F. D. & Abu-Raddad, L. J. Proc. Natl Acad. Sci. USA 107, 14757-14762 (2010).
3. Kamal, S. M. & Nasser, I. A. Hepatology 47, 1371-1383 (2008).
4. Kamel, M. A. et al. Lancet 340, 427 (1992).